Home
Resources
Publications
Different Modes of Action of the Imidazoline Compound RX871024 in Pancreatic Beta-Cells. Blocking of K+ Channels, Mobilization of Ca2+ From Endoplasmic Reticulum, and Interaction With Exocytotic Machinery

Different Modes of Action of the Imidazoline Compound RX871024 in Pancreatic Beta-Cells. Blocking of K+ Channels, Mobilization of Ca2+ From Endoplasmic Reticulum, and Interaction With Exocytotic Machinery

S V Zaitsev, A M Efanov, A Raap, I B Efanova, J Schloos, B Steckel-Hamann, O Larsson, C G Ostenson, P O Berggren, H J Mest, S Efendic

Ann N Y Acad Sci. 1999 Jun 21;881:241-52.

PMID: 10415922

Abstract:

The imidazoline compound RX871024 glucose-dependently potentiates the release of insulin in pancreatic islets and beta-cell lines. This activity of the compound is not related to its action by stimulating alpha 2-adrenoceptors and I1- and I2-imidazoline receptors. There are at least three modes of action of RX871024 in beta-cells: (1) RX871024 blocks the ATP-dependent, Ca(2+)-activated, and delayed rectifier K+ channel activity; (2) RX871024 causes mobilization of Ca2+ from thapsigargin-sensitive intracellular stores, the effect probably controlled by cytochrome P450; and (3) the stimulatory activity of RX871024 on insulin release involves interaction of the compound with the exocytotic machinery, unrelated to the changes in membrane potential and cytoplasmic-free Ca2+ concentration, whereas protein phosphorylation plays an important role in this process. The maximal insulinotropic effect of RX871024 is much higher than that of the sulfonylurea glibenclamide. RX871024 stimulates insulin release and normalizes blood glucose levels in rats in vivo without affecting blood pressure and heart rate.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP142872842	RX871024		142872-84-2	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: